Worldwide over two billion pigs have been protected against Porcine Circovirus Disease using Ingelvac CircoFLEX®
The vaccine contributes to sustainable production and supply of healthy, nutritious pork around the world like no other vaccine1
Boehringer Ingelheim Animal Health has sponsored European PRRS Research Award for the third time
The main aim of the award is to encourage research in the field of PRRS (Porcine Reproductive and Respiratory Syndrome)
Three project proposals receive funding of €25,000 each
Ingelheim, Germany, 26 September 2016 - Veterinarians and farmers across the globe have reached the landmark of protecting one billion sows and pigs against the potentially devastating effects of Porcine Reproductive and Respiratory Syndrome (PRRS) using Ingelvac PRRS MLV ®. The vaccine, which was launched in 1994 in the USA, is currently marketed in 19 countries in Asia, Europe, and North America. It contributes to securing the pigs’ health as well as providing healthy pork for consumers around the world.
More than 3,500 swine practitioners and scientists from all over the world met for four days to present and discuss swine health management at the 24th International Pig Veterinary Society (IPVS) congress in Dublin last June. Boehringer Ingelheim Animal Health (BIAH) was a partner sponsor for the event showing once again its commitment to supporting the swine industry and more importantly also contributing very actively on a rich technical and scientific program with more than 120 posters and a many oral presentations from BIAH colleagues from around the world.
Get the latest news on Swine Health Subscribe to our newsletter